Frozen Tissue Samples Market Size, Trends & Growth by 2034
Coverage: Frozen Tissue Samples Market covers analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, Morphological Analysis), End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, Other End-Users), and Geography (North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America)
- Status : Upcoming
- Report Code : TIPRE00016644
- Category : Life Sciences
- No. of Pages : 150
- Available Report Formats :
The frozen tissue samples market size is expected to reach US$236.54 million by 2034 from US$72.26 million in 2025. The market is anticipated to register a CAGR of 13.36% during 2026–2034.
Frozen Tissue Samples Market AnalysisThe frozen tissue samples market forecast indicates steady growth, driven by the rising demand for high-quality biospecimens in cancer research, precision medicine, and diagnostic applications. Increasing investments in biobanking infrastructure, advancements in cryopreservation technologies, and the growing prevalence of chronic diseases are key factors fueling market expansion. Strategic opportunities lie in the automation of biobank operations, integration with digital data ecosystems, and expansion into emerging markets with rising healthcare investments.
Frozen Tissue Samples Market OverviewFrozen tissue samples are biological specimens preserved at ultra-low temperatures (typically –80°C or below) to maintain cellular and molecular integrity for research and diagnostic purposes. These samples are critical for genomic, proteomic, and morphological studies, enabling accurate disease modeling and biomarker discovery. Applications span cancer research, personalized medicine, and clinical diagnostics. The market benefits from increasing global biobanking initiatives, stringent quality standards, and technological innovations such as automated storage systems and digital tracking solutions. Emerging economies in the Asia Pacific and Latin America present significant growth opportunities due to expanding healthcare infrastructure and research funding.
Strategic InsightsFrozen Tissue Samples Market Drivers and OpportunitiesMarket Drivers:
- Rising Demand for Cancer and Chronic Disease Research: The global surge in cancer incidence and chronic illnesses such as cardiovascular and neurological disorders is fueling demand for high-quality frozen tissue samples. These samples are essential for biomarker discovery, molecular profiling, and drug development. Governments and private organizations are investing heavily in oncology research and precision medicine programs, creating a sustained need for reliable biospecimen storage solutions.
- Advancements in Cryopreservation Technologies: Technological innovations in ultra-low temperature freezers, cryoprotectants, and automated storage systems have significantly improved sample integrity and reduced degradation risks. Modern cryopreservation techniques allow long-term storage without compromising cellular structure or molecular composition, enabling researchers to conduct retrospective studies and multi-center trials with confidence.
- Stringent Regulatory and Quality Standards: Global regulatory bodies are enforcing strict guidelines for biospecimen handling, storage, and traceability. Compliance with standards such as ISO 20387 for biobanking ensures sample quality and reproducibility, which is critical for clinical trials and translational research. This regulatory push is driving the adoption of advanced frozen tissue solutions across hospitals, diagnostic centers, and research institutes.
Market Opportunities:
- Automation of Biobanking Processes: The integration of robotics and AI-driven systems in biobanks is transforming sample management. Automated storage and retrieval systems minimize human error, enhance operational efficiency, and maintain consistent temperature control. This automation trend opens opportunities for vendors to offer turnkey biobanking solutions that combine hardware, software, and compliance features.
- Expansion in Emerging Markets: Rapid healthcare infrastructure development in the Asia Pacific, Latin America, and the Middle East is creating new demand for frozen tissue samples. Governments in these regions are launching national biobank initiatives and partnering with global research organizations. Companies that introduce cost-effective, scalable solutions tailored to these markets can gain a competitive edge and establish early leadership.
- Integration with Digital Data Ecosystems: Linking frozen tissue samples with electronic health records (EHRs), laboratory information management systems (LIMS), and research databases enables advanced analytics, personalized medicine, and AI-driven insights. This integration supports longitudinal studies, accelerates biomarker discovery, and improves reproducibility, making it a key differentiator for biobanking service providers and technology vendors.
By Product Type:
- Frozen Normal Tissue Samples: These samples are collected from healthy individuals and serve as essential controls in comparative studies. They are widely used in baseline research, validation of diagnostic assays, and biomarker development. Their role is critical in ensuring accurate differentiation between normal and diseased states in molecular and histological analyses.
- Frozen Tumor Tissue Samples: This segment dominates the market due to the growing prevalence of cancer and the surge in oncology research. Tumor samples are indispensable for genomic sequencing, proteomic profiling, and drug efficacy studies. They enable researchers to identify tumor-specific mutations, biomarkers, and therapeutic targets, making them central to precision medicine and immunotherapy development.
- Frozen Diseased Tissue Samples: These include tissues affected by chronic, infectious, or genetic diseases such as cardiovascular disorders, diabetes, and neurodegenerative conditions. They are vital for translational research, enabling scientists to study disease progression, identify molecular pathways, and develop targeted interventions. The demand for these samples is rising with the expansion of personalized medicine and rare disease research initiatives.
By Application:
- Disease Diagnosis & Treatment: Frozen tissue samples are used in histopathology, molecular diagnostics, and genetic testing to confirm disease presence and guide treatment decisions. They support personalized treatment planning by enabling accurate biomarker analysis and therapeutic response prediction.
- Cancer & Other Diseases Research: This is the largest application segment, driven by global efforts in oncology and chronic disease research. Frozen samples provide high-quality DNA, RNA, and protein for advanced studies, including next-generation sequencing (NGS), proteomics, and immunohistochemistry. They are essential for clinical trials, drug development, and biomarker validation.
- Morphological Analysis: Frozen samples preserve cellular architecture, making them ideal for structural studies and immunohistochemical staining. Researchers use these samples to examine tissue morphology, protein localization, and cellular interactions, which are critical for understanding disease mechanisms and validating therapeutic targets.
By End User:
- Academic & Research Institutes: These institutions represent the largest consumer base, leveraging frozen tissue samples for genomics, proteomics, and translational research. They play a key role in advancing scientific knowledge and developing new diagnostic and therapeutic approaches.
- Hospitals & Clinics: Hospitals utilize frozen samples for diagnostic purposes, biobanking, and retrospective clinical studies. They are integral to personalized medicine programs and pathology departments for accurate disease characterization.
- Diagnostic Centers: Diagnostic laboratories rely on frozen tissue samples for molecular testing, biomarker analysis, and genetic screening. Their use ensures high accuracy in diagnostic workflows and supports advanced testing services.
- Others: Includes pharmaceutical companies, biotechnology firms, and contract research organizations (CROs). These entities use frozen samples extensively in drug discovery, preclinical studies, and clinical trials to validate therapeutic efficacy and safety.
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
North America
- Market Share: Largest share due to advanced biobanking infrastructure and strong research funding.
- Key Drivers:
- High prevalence of cancer and chronic diseases
- Early adoption of automated storage technologies
- Strong academic and pharmaceutical research ecosystem
- Trends: Integration of biobanks with digital health platforms and precision medicine initiatives.
Europe
- Market Share: Significant share supported by stringent biospecimen standards and collaborative research networks.
- Key Drivers:
- Regulatory compliance and harmonized biobanking protocols
- Robust funding for translational research
- Growing public-private partnerships in biomedical R\&D
- Trends: Consolidation of biobank facilities and adoption of advanced cryopreservation systems.
Asia Pacific
- Market Share: Fastest-growing region driven by expanding healthcare infrastructure and research investments.
- Key Drivers:
- Rising cancer incidence and precision medicine programs
- Government-backed biobanking initiatives
- Increasing R&D expenditure by pharma and biotech companies
- Trends: Rapid adoption of automated biobank systems and digital integration.
Central & South America
- Market Share: Emerging region with growing diagnostic and research capabilities.
- Key Drivers:
- Expansion of private diagnostic labs
- Rising chronic disease burden
- International collaborations for biomedical research
- Trends: Development of regional biobank networks and cold-chain infrastructure.
Middle East & Africa
- Market Share: Developing market with increasing healthcare investments.
- Key Drivers:
- Upgrading healthcare infrastructure
- Focus on cancer and genetic disease research
- Investments from Gulf countries in biobanking projects
- Trends: Establishment of national biobanks and import of advanced cryopreservation technologies.
High Market Density and Competition
The frozen tissue samples market is highly competitive, with global and regional players focusing on product quality, compliance, and technological innovation. Differentiation strategies include:
- Automated storage and retrieval systems
- Integration with digital tracking and LIMS platforms
- Advanced cryoprotectant formulations for extended sample viability
Opportunities and Strategic Moves
- Partnerships with academic institutions and biobank networks
- Expansion into emerging markets with cost-effective solutions
- Investment in automation and digital integration for biobanking workflows
- Audubon Bioscience Co
- REPROCELL Inc.
- Bay Biosciences LLC
- US Biolab Corporation, Inc.
- AMS Biotechnology (Europe) Ltd.
- Geneticist, Inc.
- ZenBio, Inc.
- OriGene Technologies, Inc.
- BioChain Institute Inc.
- ProteoGenex, Inc.
Disclaimer: The companies listed above are not ranked in any particular order
Frozen Tissue Samples Market News and Recent Developments- In December 2025, Azenta Life Sciences launched the IntelliXcap™ M6 Semi-Automated Handheld Screw Cap Decapper, designed for 48-format screw cap tubes commonly used in biobanking and Frozen Tissue Samples storage. The device enabled quick decapping and recapping of entire columns within seconds, reducing manual effort while ensuring consistent torque to maintain sample integrity and prevent damage.
- In April 2025, BioIVT, a global research partner and biospecimen solutions provider, presented new data at the Precision Med TRI-CON conference. The data supported an innovative protocol for replicating fine needle aspirations (FNAs) in a laboratory setting using fresh Frozen Tissue Samples. Preliminary results demonstrated the method's potential for accurate molecular annotation and highlighted its promise to transform approaches to companion diagnostics development.
The "Frozen Tissue Samples Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Frozen Tissue Samples Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Frozen Tissue Samples Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Frozen Tissue Samples Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Frozen Tissue Samples Market
- Detailed company profiles
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Leading companies include Precision for Audubon Bioscience Co., REPROCELL Inc., Bay Biosciences LLC, US Biolab Corporation, Inc., AMS Biotechnology (Europe) Ltd., Geneticist, Inc., ZenBio, Inc., OriGene Technologies, Inc., BioChain Institute Inc., and ProteoGenex, Inc.
1. North America leads due to advanced infrastructure and strong research funding.
2. Asia Pacific is the fastest-growing region, driven by healthcare expansion and biobanking initiatives.
1. Automated biobanking systems for efficient storage and retrieval
2. Advanced cryoprotectant formulations for extended sample viability
3. Integration with digital data ecosystems for precision medicine
The market is expected to reach US$236.54 million by 2034 from US$72.26 million in 2025, at a CAGR of 13.36% during 2026–2034.
Key drivers include:
1. Rising demand for cancer and chronic disease research
2. Advancements in cryopreservation technologies
3. Stringent regulatory and quality standards
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
May 2026
Anesthesia Machines Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Advanced Anesthesia Machines, Basic Anesthesia Machines, and Consumables), Customer (Small Hospitals & Nursing Home, Standalone Hospitals, Tertiary Care Hospitals, and Hospital Chain), End User (Anaesthesiologists, Critical Care Specialists, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
Hospital at Home Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Equipment & Devices and Software & Services), Service Type (Acute Care at Home, Chronic Disease Management at Home, Post Acute or Transitional Care, Palliative Care and Hospice Care, and Rehabilitation Services), Delivery Mode (Remote Monitoring and Telehealth, In-person Home Visits, and Hybrid Models), Patient Demographic ( Adult Patients and Pediatric Patients), Indication (Cardiovascular Conditions, Respiratory Diseases, Orthopedic and Post-Surgical Recovery, Infectious Diseases, Neurological Rehabilitation, and Others), Care Provider (Hospitals and Health Systems, Home Health Agencies, Primary Care or Physician Groups, and Private HaH Providers), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
MRI-guided Focused Ultrasound Therapy Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Breast Cancer, Prostate Cancer, Liver Cancer, Pancreatic Cancer, Breast Lifting and Aesthetic Application, Nipple and Areola Preservation, Post Surgical Applications, and Others), End User (Healthcare Facilities, Diagnostic Imaging Centers, and Research Centers), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
Drug Delivery Devices Contract Manufacturing Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Device Type (Infusion Devices and Administration Set, Syringes, Inhalers, Autoinjectors, and Pen Injectors), Service Type (Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
IVD Devices Contract Manufacturing Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Full-device Manufacturing, Sub-assembly and Components, and Materials-specific Services), Device Type (IVD consumables, IVD equipment), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
Gene Therapy CDMO Market
Size and Forecast (2021 - 2034), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Other Service Types), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
May 2026
RT-PCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
May 2026
dPCR Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Get Free Sample For